Olivia Rodrigo’s new single “The Cure” landed at No. 5 on the Billboard Hot 100 this week, reinforcing momentum as she counts down to her next album. The song’s high debut — and its place atop the Hot Rock & Alternative Songs chart — matters now because it shows sustained public interest amid heavy competition from Drake and breakout acts like Ella Langley.
Where the numbers stand
“The Cure” opened in the Hot 100 top five the week after Rodrigo’s lead single, “Drop Dead,” debuted at No. 1 — Rodrigo’s fourth song to enter the chart at the summit. The follow-up also reached No. 1 on the Hot Rock & Alternative Songs chart, marking her third leader there after “Brutal” (2021) and “Bad Idea Right?” (2023).
Industry observers see the No. 5 start as a win given the current chart context: Drake’s multi-album surge and Ella Langley’s persistent mainstream presence crowded an unusually competitive week.
Critical reaction in brief
Staff writers weighed in on what the debut means for Rodrigo’s campaign. Their reactions ranged from pragmatic to enthusiastic:
- Top-five verdicts: Most critics rated a No. 5 debut as strong, if not the ideal outcome, noting Rodrigo already proved her commercial pull with “Drop Dead.”
- Context matters: Several commentators emphasized that chart position this week carries extra weight because of Drake’s and Langley’s dominance.
- Artistic value: Some praised “The Cure” for its bold, five-plus-minute, confessional approach — a riskier single choice that still connected with listeners.
Album structure and which half intrigues critics
Rodrigo’s forthcoming album, titled You Seem Pretty Sad for a Girl So in Love, is split into two thematic sides: girl so in love and you seem pretty sad. “Drop Dead” opens the first half; “The Cure” leads the second.
Across the board, most editors said they are more curious about the darker, second section. They cited the emotional complexity hinted at in “The Cure” and suggested that Rodrigo’s most compelling material may live in the album’s more anguished territory.
Why the second side resonates
Critics pointed to the song’s gradual build and its willingness to embrace a rawer rock palette as reasons the “sad” half promises deeper rewards. For many, hearing Rodrigo push into moodier, less radio-ready territory makes the forthcoming record feel riskier and more interesting.
Sound and influences: who’s in the room?
“The Cure” wears its 1990s alt-rock influences on its sleeve, and contributors suggested a handful of likely touchstones Rodrigo might explore across the album.
- The Cure / Smashing Pumpkins: These bands were the most commonly cited reference points for the single’s sonic colors.
- Talking Heads / David Byrne: Some editors flagged Byrne’s recent cover of “Drivers License” and his onstage connection with Rodrigo as a potential link.
- Avril Lavigne, Jack White, The Cranberries, Depeche Mode: Other readers and critics named these acts as plausible signposts for Rodrigo’s expanded rock-leaning palette.
What critics hope to see before release
With the album due in two weeks, writers suggested a few moves Rodrigo could make to sharpen the rollout — some pragmatic, some playful.
Ideas ranged from targeted media moments that acknowledge the personal material behind the songs to creative brand collaborations and immersive fan events that play with the album’s dual themes.
- Stirring conversation: A pointed interview moment could amplify attention around the record’s confessional content.
- Brand tie-in: Lighter suggestions included a novelty collaboration (think seasonal food or merch) to broaden visibility.
- Two-sided rollout: Host separate launch events aligned with each half of the album, giving fans different experiences and fueling online speculation.
For now, the story is one of sustained curiosity. A No. 5 Hot 100 debut plus a rock-chart leader confirms Rodrigo remains a cultural force — and the next fortnight will reveal whether she uses the remaining promotional runway to deepen the album’s narrative or to accelerate its commercial lift.
